ORPHELIA Pharma
3 products tracked · names used in filings: ORPHELIA Pharma
Upcoming milestones
Mon 21 Dec 2026🇪🇺 Expected EC decisionestimatein 37 days
Kizfizo (temozolomide): expected EC decision
Estimated as CHMP opinion (2026-10-15) + 67 days, the standard Commission decision period. Not an official date. · ORPHELIA Pharma · source
Recent milestones
Thu 15 Oct 2026🇪🇺 CHMP positive opinion
Kizfizo (temozolomide): CHMP positive opinion
ORPHELIA Pharma; Orphan · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Kizfizo temozolomide | Opinion | |
| 🇪🇺 | Kizfizo temozolomide | Refused | |
| 🇪🇺 | Ivozall clofarabine | Withdrawn | 2019-11-14 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.